ロード中...
Real-life experience using trabectedin plus pegylated liposomal doxorubicin combination to treat patients with relapsed ovarian cancer
The goal of recurrent ovarian cancer (ROC) treatment is no longer just palliation, but prolonging survival. This is usually through administering a new line of chemotherapy at each relapse. A novel treatment sequencing strategy to achieve this is through the intercalation of an effective non-platinu...
保存先:
| 出版年: | EJC Suppl |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4683382/ https://ncbi.nlm.nih.gov/pubmed/26759528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1359-6349(15)70006-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|